EU panel backs Hopledo for Parkinson's motor fluctuations
Zambon and Amneal Pharmaceuticals (Nasdaq: AMRX) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
